jonaswalheim.bsky.social
@jonaswalheim.bsky.social
Founder | Medical Data x AI
https://navis-bio.com
Use MCP to interrogate clinicaltrials.cov. Back in December, as @anthropic.com released MCP, we directly linked it to AACT. Happy to share our case study with the Clinical Trials Transformation Initiative (CTTI) connects.ctti-clinicaltrials.org/show/57
May 3, 2025 at 7:14 PM
Happy to release the latest version of our MCP server for biomedical data in BigQuery. This update enables interaction with comprehensive biomedical data sources using Claude AI or any MCP-compatible LLM client. We're reducing hallucinations by letting LLMs interact directly with the databases.
January 4, 2025 at 5:24 PM
We often hear biopharma would be a super small market with only a couple of hundred biotech companies. But no one could really give us a number. So we had a look at biopharma companies with clinical stage activities:

4431 unique biopharma companies initiated trials in the last 5 years!
December 21, 2024 at 8:20 AM
What's the right value proposition for gen AI in biopharma? Here's what we were told in numerous conversations with biopharma decision makers.
What is your experience?
December 19, 2024 at 5:17 PM
Assess therapeutic targets in @opentargets.org in natural language and have Claude create dashboards on the fly.

We just built another integration for @anthropic.com 's Model Context Protocol (MCP) to enable Claude to get insights from the OpenTargets platform.

github.com/navisbio/mcp...
December 17, 2024 at 5:53 AM
Claude for translational medical research. We built an interface to AACT/clinicaltrials.gov with the MCP protocol by @anthropic.com
Ask Claude to analyze trial design, biomarkers, outcomes, etc. and give you insights on the trial landscape.

navis-bio.com#MCP-ctgov
github.com/navisbio/ctg...
December 9, 2024 at 6:56 AM